论文部分内容阅读
目的探讨福辛普利联合替米沙坦治疗糖尿病肾病的有效性。方法对36例糖尿病肾病患者随机分为治疗组和对照组,两组均予严格控制血糖,低蛋白饮食。对照组仅使用福辛普利,治疗组在福辛普利的基础上联合替米沙坦。结果两组均能减少24h尿蛋白总量和尿白蛋白/肌酐,而治疗组较明显。结论福辛普利联合替米沙坦治疗糖尿病肾病是显效的。
Objective To investigate the effectiveness of fosinopril combined with telmisartan in the treatment of diabetic nephropathy. Methods Thirty-six patients with diabetic nephropathy were randomly divided into treatment group and control group. Both groups were given strict control of blood sugar and low protein diet. The control group only used fosinopril, and the treatment group combined with telmisartan on the basis of fosinopril. Results Both groups were able to reduce 24-hour urinary albumin and albumin / creatinine, but the treatment group was more obvious. Conclusion Fosinopril in combination with telmisartan is effective in treating diabetic nephropathy.